The U.S. government has labeled Colombia as a nation that has “demonstrably failed” to meet its international drug-fighting commitments, according to the latest Majors List for fiscal year 2027. The classification, announced in a September 2026 presidential directive, now applies to four countries: Afghanistan, Bolivia, Myanmar, and Colombia. This reassessment comes after evaluating policies under former President Gustavo Petro, whose term concluded on August 7, 2024. The report notes an increase in coca cultivation and cocaine output during his presidency, though it leaves room for change under the new leadership of Abelardo de la Espriella.
The Majors List currently includes 23 nations identified as major transit or production centers for illegal drugs. Colombia’s placement on the list highlights ongoing difficulties in eliminating coca crops and dismantling drug-related criminal organizations. U.S. officials have pinpointed two critical areas requiring improvement: reducing coca cultivation and targeting criminal groups involved in drug trafficking. The Trump administration’s decision to remove Venezuela from the “demonstrably failed” category, while keeping it on the broader list of drug-producing or transit nations, contrasts with Colombia’s current status.
U.S. authorities have made clear that Colombia’s position may be reconsidered if de la Espriella’s government meets its pledges to speed up coca eradication and disrupt narcoterrorist networks. The directive suggests that collaborative efforts with U.S. agencies could prompt a review within the next 12 months. The move is framed as a conditional opportunity rather than a definitive penalty, with the focus remaining on tangible outcomes rather than immediate penalties.
Read Also: Students must know their rights before signing rental contracts
While the designation carries diplomatic consequences, it does not automatically impose sanctions. Instead, the emphasis is on measurable progress, particularly in regions where coca production surged during Petro’s tenure. The U.S. has indicated it will maintain engagement if Colombia demonstrates real advancements in key performance areas.
De la Espriella’s administration now faces significant challenges as it takes over a volatile security environment. Past U.S. policy has linked aid and cooperation to proven counter-narcotics results, and whether the new government can meet those expectations will determine whether Colombia can avoid the “demonstrably failed” classification. The decision reflects the U.S. expectation that Colombia will prioritize drug control efforts to restore its standing in international counter-narcotics partnerships.
